160 related articles for article (PubMed ID: 7976789)
1. Antihistaminic drug bromadryl and stimulated platelet aggregation.
Nosál R; Jancinová V; Petríková M
Agents Actions; 1994 Jun; 41 Spec No():C104-5. PubMed ID: 7976789
[TBL] [Abstract][Full Text] [Related]
2. [The effect of antihistamines on stimulated blood platelet functions].
Nosál R; Jancinová V; Petríková M
Cesk Fysiol; 1995 Mar; 44(1):21-3. PubMed ID: 7758143
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological intervention with platelet phospholipase A2.
Nosal R; Jancinova V
Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
[TBL] [Abstract][Full Text] [Related]
4. Effect of the antihistaminic drug Bromadryl on ex vivo platelet functions during gestation in rats.
Jancinová V; Petríková M; Ujházy E; Nosál R
Agents Actions; 1994 Jun; 41 Spec No():C101-3. PubMed ID: 7976788
[TBL] [Abstract][Full Text] [Related]
5. Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)).
Nosál R; Jancinová V
Thromb Res; 2002 Feb; 105(4):339-45. PubMed ID: 12031829
[TBL] [Abstract][Full Text] [Related]
6. On the effect of the antihistaminic drug bromadryl on human platelets in vitro.
Jancinová V; Nosál R; Danihelová E
Inflamm Res; 1996 Mar; 45 Suppl 1():S21-2. PubMed ID: 8696912
[No Abstract] [Full Text] [Related]
7. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties.
Jancinová V; Májeková M; Nosál R; Petríková M
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):191-3. PubMed ID: 8735816
[TBL] [Abstract][Full Text] [Related]
8. The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane production in vitro.
Nosál R; Jancinová V; Petríková M
Inflamm Res; 1995 Apr; 44 Suppl 1():S14-5. PubMed ID: 8520978
[No Abstract] [Full Text] [Related]
9. Decreased arachidonic acid liberation participates in the anti-aggregatory effect of the histamine H(1)-receptor antagonist Bromadryl.
Jacinová V; Nosál R; Danihelová E
Platelets; 1999; 10(6):391-8. PubMed ID: 16801118
[TBL] [Abstract][Full Text] [Related]
10. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
11. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro.
Nosál R; Jancinová V; Danihelová E
Inflamm Res; 1996 Mar; 45 Suppl 1():S29-30. PubMed ID: 8696916
[No Abstract] [Full Text] [Related]
12. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
Qu YZ; Li XX
Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
[TBL] [Abstract][Full Text] [Related]
13. Effect of the H1-antagonist bromadryl on mast cells in pregnant rats ex vivo.
Drábiková K; Pecivová J; Ujházy E; Nosál R
Inflamm Res; 1995 Apr; 44 Suppl 1():S36-7. PubMed ID: 8520990
[No Abstract] [Full Text] [Related]
14. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
15. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
Nosál R; Petríková M; Jancinová V
J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine: a multipotent inhibitor of human platelets in vitro.
Nosál' R; Jancinová V; Danihelová E
Thromb Res; 2000 Jun; 98(5):411-21. PubMed ID: 10828481
[TBL] [Abstract][Full Text] [Related]
18. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
[TBL] [Abstract][Full Text] [Related]
19. Impaired platelet aggregation and thromboxane generation in essential fatty acid-deficient rats.
Takahashi R; Manku MS; Horrobin DF
J Nutr; 1987 Sep; 117(9):1520-6. PubMed ID: 2888839
[TBL] [Abstract][Full Text] [Related]
20. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
